{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:13:04Z","timestamp":1791357184403,"version":"4.3.1"},"reference-count":94,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:00:00Z","timestamp":1459900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1002\/da.22505","type":"journal-article","created":{"date-parts":[[2016,4,10]],"date-time":"2016-04-10T15:52:49Z","timestamp":1460303569000},"page":"698-710","source":"Crossref","is-referenced-by-count":111,"title":["KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE"],"prefix":"10.1155","volume":"33","author":[{"given":"William V.","family":"Bobo","sequence":"first","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Vande Voort","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Croarkin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susannah J.","family":"Tye","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Frye","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Psychology; Mayo Clinic; Rochester Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,6]]},"reference":[{"key":"10.1002\/da.22505-BIB0001|da22505-cit-0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrn1846","article-title":"New approaches to antidepressant drug discovery: beyond monoamines","volume":"7","author":"Berton","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"10.1002\/da.22505-BIB0002|da22505-cit-0002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0006-3223(03)00087-8","article-title":"Acceleration and augmentation strategies for treating bipolar depression","volume":"53","author":"Altshuler","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0003|da22505-cit-0003","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/nyas.12718","article-title":"Ketamine as a promising prototype for a new generation of rapid-acting antidepressants","volume":"1344","author":"Abdallah","year":"2015","journal-title":"Ann N Y Acad Sci"},{"key":"10.1002\/da.22505-BIB0004|da22505-cit-0004","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1399-6576.1998.tb05316.x","article-title":"Ketamine analgesia, NMDA receptors and the gates perception","volume":"42","author":"\u00d8ye","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1002\/da.22505-BIB0005|da22505-cit-0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/bja\/53.1.27","article-title":"Pharmacokinetics and analgesic effect of ketamine in man","volume":"52","author":"Clements","year":"1981","journal-title":"Br J Anaesth"},{"key":"10.1002\/da.22505-BIB0006|da22505-cit-0006","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/bja\/70.6.666","article-title":"Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method","volume":"70","author":"Geisslinger","year":"1993","journal-title":"Br J Anaesth"},{"key":"10.1002\/da.22505-BIB0007|da22505-cit-0007","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/517130a","article-title":"Rave drug tested against depression","volume":"517","author":"Reardon","year":"2015","journal-title":"Nature"},{"key":"10.1002\/da.22505-BIB0008|da22505-cit-0008","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1176\/appi.ajp.2014.14030354","article-title":"Electroconvulsive therapy is a standard treatment; ketamine is not (yet)","volume":"171","author":"Kellner","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0009|da22505-cit-0009","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pnpbp.2015.01.002","article-title":"Has psychiatry tamed the \u201cketamine tiger?\u201d Considerations on its use for depression and anxiety","volume":"64","author":"Rasmussen","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0010|da22505-cit-0010","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2012.12020219","article-title":"Long-term maintenance with intramuscular ketamine for treatment-resistant bipolar II depression","volume":"169","author":"Cusin","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0011|da22505-cit-0011","first-page":"48","article-title":"Maintenance ketamine treatment produces long-term recovery from depression","volume":"17","author":"Messer","year":"2010","journal-title":"Primary Psychiatry"},{"key":"10.1002\/da.22505-BIB0012|da22505-cit-0012","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/jnp.2010.22.4.442","article-title":"The use of a series of ketamine infusions in two patients with treatment-resistant depression","volume":"22","author":"Messer","year":"2010","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1002\/da.22505-BIB0013|da22505-cit-0013","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/jcph.122","article-title":"Repeated S-ketamine infusions in therapy resistant depression: a case series","volume":"53","author":"Segmiller","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1002\/da.22505-BIB0014|da22505-cit-0014","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jad.2012.10.015","article-title":"A 12-month naturalistic observation of three patients receiving repeat intravenous ketamine infusions for their treatment-resistant depression","volume":"147","author":"Szymkowicz","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1002\/da.22505-BIB0015|da22505-cit-0015","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1176\/appi.ajp.2014.13101434","article-title":"A word to the wise about ketamine","volume":"171","author":"Schatzberg","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0016|da22505-cit-0016","first-page":"7854","article-title":"The secret life of ketamine","volume":"294","author":"Lawrence","year":"2015","journal-title":"Pharm J"},{"key":"10.1002\/da.22505-BIB0017|da22505-cit-0017","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biopsych.2012.05.003","article-title":"Ketamine for depression: where do we go from here?","volume":"72","author":"aan het Rot","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0018|da22505-cit-0018","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1176\/appi.ajp.2013.13081034","article-title":"Ketamine for treatment-resistant depression: ready or not for clinical use?","volume":"170","author":"Rush","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0019|da22505-cit-0019","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/wps.20269","article-title":"Ketamine for depression: evidence, challenges and promise","volume":"14","author":"Zarate","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1002\/da.22505-BIB0020|da22505-cit-0020","unstructured":"Ketamine Advocacy Network http:\/\/www.ketamineadvocacynetwork.org\/ 2015"},{"key":"10.1002\/da.22505-BIB0021|da22505-cit-0021","article-title":"Club drug ketamine gains traction as a treatment for depression","author":"Hamilton","journal-title":"National Public Radio"},{"key":"10.1002\/da.22505-BIB0022|da22505-cit-0022","unstructured":"Pollack A Special K, a hallucinogen, raises hopes and concerns as a treatment for depression The New York Times 2014 http:\/\/www.nytimes.com\/2014\/12\/10\/business\/special-k-a-hallucinogen-raises-hopes-and-concerns-as-a-treatment-for-depression.html?_r=0"},{"key":"10.1002\/da.22505-BIB0023|da22505-cit-0023","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4088\/JCP.09m05327blu","article-title":"Rapid resolution of suicidal ideation after a single infusion of an NMDA antagonist in patients with treatment-resistant major depressive disorder","volume":"71","author":"Diazgranados","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22505-BIB0024|da22505-cit-0024","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2009.04.029","article-title":"Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression","volume":"66","author":"Price","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0025|da22505-cit-0025","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.biopsych.2011.12.010","article-title":"Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial","volume":"71","author":"Zarate","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0026|da22505-cit-0026","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jpsychires.2014.07.027","article-title":"Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety","volume":"58","author":"Ballard","year":"2014","journal-title":"J Psychiatr Res"},{"key":"10.1002\/da.22505-BIB0027|da22505-cit-0027","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1017\/S0033291715001506","article-title":"Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial","volume":"45","author":"Murrough","year":"2015","journal-title":"Psychol Med"},{"key":"10.1002\/da.22505-BIB0028|da22505-cit-0028","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s40268-015-0081-0","article-title":"Ketamine as a potential treatment for suicidal ideation: a systematic review of the literature","volume":"15","author":"Reinstatler","year":"2015","journal-title":"Drugs R D"},{"key":"10.1002\/da.22505-BIB0029|da22505-cit-0029","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-007-0061-3","article-title":"STAR*D project results: a comprehensive review of findings","volume":"9","author":"Warden","year":"2007","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"10.1002\/da.22505-BIB0030|da22505-cit-0030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1001\/archpsyc.59.6.530","article-title":"The long-term natural history of the weekly symptomatic status of bipolar I disorder","volume":"59","author":"Judd","year":"2002","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1002\/da.22505-BIB0031|da22505-cit-0031","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/archpsyc.60.3.261","article-title":"A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder","volume":"60","author":"Judd","year":"2003","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1)","key":"10.1002\/da.22505-BIB0032|da22505-cit-0032","first-page":"S17","article-title":"Current landscape, unmet needs, and future directions for treatment of bipolar depression","volume":"169","author":"Frye","year":"2015","journal-title":"J Affect Disord"},{"key":"10.1002\/da.22505-BIB0033|da22505-cit-0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.163.2.217","article-title":"Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)","volume":"163","author":"Perlis","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0034|da22505-cit-0034","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1034\/j.1399-5618.2003.00051.x","article-title":"An overview of recent findings of the Stanley Foundation Bipolar Network, pt 1","volume":"5","author":"Post","year":"2003","journal-title":"Bipolar Disord"},{"key":"10.1002\/da.22505-BIB0035|da22505-cit-0035","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1176\/ajp.152.11.1635","article-title":"Relapse and impairment in bipolar disorder","volume":"152","author":"Gitlin","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0036|da22505-cit-0036","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1176\/appi.ajp.158.3.420","article-title":"Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder","volume":"158","author":"McElroy","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0037|da22505-cit-0037","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bdi.12243","article-title":"Medical burden in bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE)","volume":"17","author":"Sylvia","year":"2015","journal-title":"Bipolar Disord"},{"key":"10.1002\/da.22505-BIB0038|da22505-cit-0038","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","article-title":"Suicidal behavior in bipolar disorder: risk and prevention","volume":"17","author":"Tondo","year":"2003","journal-title":"CNS Drugs"},{"issue":"3S2","key":"10.1002\/da.22505-BIB0039|da22505-cit-0039","first-page":"S195","article-title":"Existing and noval biological therapeutics in suicide prevention","volume":"47","author":"Griffiths","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1002\/da.22505-BIB0040|da22505-cit-0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881114527361","article-title":"Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic","volume":"28","author":"Diamond","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1002\/da.22505-BIB0041|da22505-cit-0041","article-title":"Effects of low-dose and very low-dose ketamine among patients with major depression: a systematic review and meta-analysis","author":"Xu","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/da.22505-BIB0042|da22505-cit-0042","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0043|da22505-cit-0043","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1017\/S0033291714001603","article-title":"A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes","volume":"45","author":"McGirr","year":"2015","journal-title":"Psychol Med"},{"key":"10.1002\/da.22505-BIB0044|da22505-cit-0044","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.genhosppsych.2015.01.003","article-title":"Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis","volume":"37","author":"Lee","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1002\/da.22505-BIB0045|da22505-cit-0045","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1002\/da.22505-BIB0046|da22505-cit-0046","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hup.2475","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis","volume":"30","author":"Coyle","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"10.1002\/da.22505-BIB0047|da22505-cit-0047","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/PRA.0000000000000106","article-title":"Efficacy of ketamine in bipolar depression: systematic review and meta-analysis","volume":"21","author":"Parsaik","year":"2015","journal-title":"J Psychiatr Pract"},{"key":"10.1002\/da.22505-BIB0048|da22505-cit-0048","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-014-3664-5","article-title":"Ketamine administration in depressive disorders: a systematic review and meta-analysis","volume":"231","author":"Fond","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1002\/da.22505-BIB0049|da22505-cit-0049","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/2045125313507739","article-title":"Ketamine as the prototype glutamatergic antidepressant: pharmacodynamics actions, and a systematic review and meta-analysis of efficacy","volume":"4","author":"Caddy","year":"2014","journal-title":"Ther Adv Psychopharmacol"},{"key":"10.1002\/da.22505-BIB0050|da22505-cit-0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/clpt.2011.244","article-title":"Ketamine as a novel antidepressant: from synapse to behavior","volume":"91","author":"Murrough","year":"2012","journal-title":"Clin Pharm Ther"},{"key":"10.1002\/da.22505-BIB0051|da22505-cit-0051","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0052|da22505-cit-0052","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","article-title":"A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression","volume":"63","author":"Zarate","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22505-BIB0053|da22505-cit-0053","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archgenpsychiatry.2010.90","article-title":"A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression","volume":"67","author":"Diazgranados","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22505-BIB0054|da22505-cit-0054","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0055|da22505-cit-0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","article-title":"Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression","volume":"74","author":"Murrough","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0056|da22505-cit-0056","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269881113478283","article-title":"Serial infusions of low-dose ketamine for major depression","volume":"27","author":"Rasmussen","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1002\/da.22505-BIB0057|da22505-cit-0057","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S1461145714001011","article-title":"Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression","volume":"17","author":"Shiroma","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1002\/da.22505-BIB0058|da22505-cit-0058","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3109\/15622975.2014.922697","article-title":"Pilot dose-response trial of i.v. ketamine in treatment-resistant depression","volume":"15","author":"Lai","year":"2014","journal-title":"World J Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0059|da22505-cit-0059","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","author":"Cusin","year":"2016","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1002\/da.22505-BIB0060|da22505-cit-0060","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4088\/JCP.13m08852","article-title":"Ketamine safety and tolerability in clinical trials for treatment-resistant depression","volume":"76","author":"Wan","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22505-BIB0061|da22505-cit-0061","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"10.1002\/da.22505-BIB0062|da22505-cit-0062","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.psychres.2013.12.008","article-title":"Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder","volume":"215","author":"Ghasemi","year":"2014","journal-title":"Psychiatry Res"},{"key":"10.1002\/da.22505-BIB0063|da22505-cit-0063","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2015.01.003","article-title":"A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability","volume":"62","author":"McGirr","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1002\/da.22505-BIB0064|da22505-cit-0064","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1111\/bph.13222","article-title":"Ketmaine and phencyclidine: the good, the bad and the unexpected","volume":"172","author":"Lodge","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1002\/da.22505-BIB0065|da22505-cit-0065","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10550490290088126","article-title":"Ketamine as a preferred substance of abuse","volume":"11","author":"Bobo","year":"2002","journal-title":"Am J Addict"},{"key":"10.1002\/da.22505-BIB0066|da22505-cit-0066","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1176\/appi.ajp.2015.15081082","article-title":"Potential risks of poorly monitored ketamine use in depression treatment","volume":"173","author":"Schak","year":"2016","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0067|da22505-cit-0067","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/ajad.12153","article-title":"Intensive ketamine use for multiple years: a case report","volume":"24","author":"Liu","year":"2015","journal-title":"Am J Addict"},{"key":"10.1002\/da.22505-BIB0068|da22505-cit-0068","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.3402\/ehtj.v4i0.7107","article-title":"The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use","volume":"4","author":"Kalsi","year":"2011","journal-title":"Emerg Health Threats J"},{"key":"10.1002\/da.22505-BIB0069|da22505-cit-0069","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"key":"10.1002\/da.22505-BIB0070|da22505-cit-0070","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/add.12228","article-title":"Ketamine and damage to the urinary tract","volume":"108","author":"Wood","year":"2013","journal-title":"Addiction"},{"key":"10.1002\/da.22505-BIB0071|da22505-cit-0071","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fnana.2013.00023","article-title":"Brain damages in ketamine addicts as revealed by magnetic resonance imaging","volume":"7","author":"Wang","year":"2013","journal-title":"Front Neuroanat"},{"key":"10.1002\/da.22505-BIB0072|da22505-cit-0072","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.neulet.2012.06.009","article-title":"Alterations in regional homogeneity of resting-state brain activity in ketamine addicts","volume":"522","author":"Liao","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.1002\/da.22505-BIB0073|da22505-cit-0073","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/npp.2014.298","article-title":"Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial","volume":"40","author":"Murrough","year":"2015","journal-title":"Neuorpsychopharmacology"},{"key":"10.1002\/da.22505-BIB0074|da22505-cit-0074","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Neuchterlein","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0075|da22505-cit-0075","article-title":"Neurocognitive effects of ketamine in treamtent-resistant major depression: association with antidepressant response","author":"Murrough","year":"2013","journal-title":"Psychopharmacol (Berl)"},{"key":"10.1002\/da.22505-BIB0076|da22505-cit-0076","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1002\/da.22505-BIB0077|da22505-cit-0077","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1185\/030079908X291958","article-title":"The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach","volume":"24","author":"Duru","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1002\/da.22505-BIB0078|da22505-cit-0078","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMcp1000402","article-title":"Clinical practice. Bipolar disorder-a focus on depression","volume":"364","author":"Frye","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1002\/da.22505-BIB0079|da22505-cit-0079","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1002\/da.22505-BIB0080|da22505-cit-0080","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1002\/da.22505-BIB0081|da22505-cit-0081","first-page":"287","article-title":"Relationship of ketamine's antidepressant and psychotomimetic effects in unipolar depression","volume":"34","author":"Sos","year":"2013","journal-title":"Neuroendocrinol Lett"},{"key":"10.1002\/da.22505-BIB0082|da22505-cit-0082","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0000000000000316","article-title":"Concomitant benzodiazepine use attenuates ketamine response: implications for large scale study design and clinical development","volume":"35","author":"Frye","year":"2015","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/da.22505-BIB0083|da22505-cit-0083","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archpsyc.62.4.427","article-title":"Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers","volume":"62","author":"Qin","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22505-BIB0084|da22505-cit-0084","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4088\/JCP.13r08722","article-title":"Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration","volume":"75","author":"Borges","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22505-BIB0085|da22505-cit-0085","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1002\/da.22505-BIB0086|da22505-cit-0086","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/YCT.0b013e3182455758","article-title":"Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?","volume":"28","author":"Rabheru","year":"2012","journal-title":"J ECT"},{"key":"10.1002\/da.22505-BIB0087|da22505-cit-0087","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1038\/npp.2011.338","article-title":"Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study","volume":"37","author":"Ibrahim","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/da.22505-BIB0088|da22505-cit-0088","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4088\/JCP.14l09527","article-title":"Single-dose ketamine followed by daily d-cycloserine in treatment-resistant bipolar depression","volume":"76","author":"Kantrowitz","year":"2015","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/da.22505-BIB0089|da22505-cit-0089","article-title":"Ketmaine-a narrative review of its uses in medicine","author":"Radvansky","year":"2015","journal-title":"Am J Ther"},{"key":"10.1002\/da.22505-BIB0090|da22505-cit-0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2165\/00002018-200831100-00004","article-title":"Comparative risk for harms of second-generation antidepressants : a systematic review and meta-analysis","volume":"31","author":"Gartlehner","year":"2008","journal-title":"Drug Saf"},{"key":"10.1002\/da.22505-BIB0091|da22505-cit-0091","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1360-0443.2006.01494.x","article-title":"A case of ketamine dependence with discontinuation symptoms","volume":"101","author":"Critchlow","year":"2006","journal-title":"Addiction"},{"key":"10.1002\/da.22505-BIB0092|da22505-cit-0092","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/002204260703700311","article-title":"Prevalence and patterns of prescription drug misuse among young ketamine injectors","volume":"37","author":"Lankenau","year":"2007","journal-title":"J Drug Issues"},{"key":"10.1002\/da.22505-BIB0093|da22505-cit-0093","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1001\/jamapsychiatry.2013.2105","article-title":"Addressing risks to advance mental health research","volume":"70","author":"Iltis","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1002\/da.22505-BIB0094|da22505-cit-0094","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"Hazell","year":"2006","journal-title":"Drug Saf"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22505","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22505","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/da.22505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:04:37Z","timestamp":1671541477000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22505"}},"subtitle":["Review: Ketamine Clinics for Treatment-Resistant Depression"],"short-title":[],"issued":{"date-parts":[[2016,4,6]]},"references-count":94,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22505","archive":["Portico"],"relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4,6]]}}}